Pioneering immune therapy trial offers new hope for kids with recurrent brain cancer

This is a small, early-stage study testing a complex, personalized immune therapy for children and young adults whose medulloblastoma, a type of brain cancer, has come back. The goal is to see if it's safe and possible to combine several treatments: a custom-made vaccine, specially grown immune cells, stem cells, and a drug that helps the immune system attack the cancer. The study will enroll up to 12 participants to check for safety and whether the multi-step treatment can be successfully manufactured and delivered.